152 related articles for article (PubMed ID: 11592833)
1. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.
Ko KS; Lee M; Koh JJ; Kim SW
Mol Ther; 2001 Oct; 4(4):313-6. PubMed ID: 11592833
[TBL] [Abstract][Full Text] [Related]
2. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice.
Koh JJ; Ko KS; Lee M; Han S; Park JS; Kim SW
Gene Ther; 2000 Dec; 7(24):2099-104. PubMed ID: 11223991
[TBL] [Abstract][Full Text] [Related]
3. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
Chang Y; Prud'homme GJ
J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 plasmid construction and delivery for the prevention of type 1 diabetes.
Lee M; Park H; Youn J; Oh ET; Ko K; Kim S; Park Y
Ann N Y Acad Sci; 2006 Oct; 1079():313-9. PubMed ID: 17130572
[TBL] [Abstract][Full Text] [Related]
6. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.
Moritani M; Yoshimoto K; Ii S; Kondo M; Iwahana H; Yamaoka T; Sano T; Nakano N; Kikutani H; Itakura M
J Clin Invest; 1996 Oct; 98(8):1851-9. PubMed ID: 8878437
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O
J Autoimmun; 1996 Oct; 9(5):645-51. PubMed ID: 8933280
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular injection of interleukin-10 plasmid DNA prevented autoimmune diabetes in mice.
Zhang ZL; Shen SX; Lin B; Yu LY; Zhu LH; Wang WP; Luo FH; Guo LH
Acta Pharmacol Sin; 2003 Aug; 24(8):751-6. PubMed ID: 12904273
[TBL] [Abstract][Full Text] [Related]
9. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
10. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
Jiang TJ; Zhou ZG; Su H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
13. More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice.
Seifarth C; Pop S; Liu B; Wong CP; Tisch R
J Immunol; 2003 Jul; 171(1):469-76. PubMed ID: 12817032
[TBL] [Abstract][Full Text] [Related]
14. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice.
Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M
J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366
[TBL] [Abstract][Full Text] [Related]
15. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.
Zheng XX; Steele AW; Hancock WW; Stevens AC; Nickerson PW; Roy-Chaudhury P; Tian Y; Strom TB
J Immunol; 1997 May; 158(9):4507-13. PubMed ID: 9127018
[TBL] [Abstract][Full Text] [Related]
16. Prevention of autoimmune insulitis by delivery of interleukin-4 plasmid using a soluble and biodegradable polymeric carrier.
Lee M; Koh JJ; Han SO; Ko KS; Ki SW
Pharm Res; 2002 Mar; 19(3):246-9. PubMed ID: 11934229
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
18. Cytokine regulatory effects on alpha-1 proteinase inhibitor expression in NOD mouse islet endothelial cells.
Papaccio G; Pedullà M; Ammendola E; Todaro M
J Cell Biochem; 2002; 85(1):123-30. PubMed ID: 11891856
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy of experimental autoimmune thyroiditis mice by in vivo administration of plasmid DNA coding for human interleukin-10.
Zhang ZL; Lin B; Yu LY; Shen SX; Zhu LH; Wang WP; Guo LH
Acta Pharmacol Sin; 2003 Sep; 24(9):885-90. PubMed ID: 12956936
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.
Goudy K; Song S; Wasserfall C; Zhang YC; Kapturczak M; Muir A; Powers M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Ellis TM; Flotte TR; Atkinson MA
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13913-8. PubMed ID: 11717448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
